Capecitabine-mediated heart failure in colorectal cancer: a case series

BACKGROUND: Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1–18% of patients receiving Capecitabine. The most commonly proposed mechanism of cardiotoxicity in the...

Descripción completa

Detalles Bibliográficos
Autores principales: McAndrew, Erin N, Jassal, Davinder S, Goldenberg, Benjamin A, Kim, Christina A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936921/
https://www.ncbi.nlm.nih.gov/pubmed/33709051
http://dx.doi.org/10.1093/ehjcr/ytab079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936921/
https://www.ncbi.nlm.nih.gov/pubmed/33709051
http://dx.doi.org/10.1093/ehjcr/ytab079

Ejemplares similares